• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II AUI STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II AUI STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number ETUF2814C102E
Medical Device Problem Code Difficult to Remove (1528)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/27/2026
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during the index procedure to treat a 55mm aneurysm with the stent graft etuf2814c102e endur ii aui.After the stent graft was deployed when attempting to recapture, the nose cone would not recapture.Following the ifu the device was opened however the device would still not recapture the nose cone.Per the physician the cause of the event was device related.No patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Additional information received: it was reported that the device was removed after all attempts to recapture were unsuccessful, and no vessel damage was observed upon device removal.It was confirmed that the device was inspected prior to insertion, and no issues were identified.Film evaluation summary: the reported difficulty retracting the tip into the graft cover could not be assessed based on the pre-implant images available; therefore, the cause of the event cannot be determined.Procedural angiograms demonstrating device advancement into the vessel, stent graft deployment, attempts to retract the tip, and device removal were not available for a comprehensive assessment of the reported event.Analysis of the available images did not reveal any obvious anatomical features that could have contributed to this event.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Product analysis the device was received with the distal end of the screw gear and the front grip detached.Kinks were evident along the graft cover and deformation was evident at the distal edge of the graft cover.Separation was observed to the distal end of the spiral member.It was not possible to move the external slider due to the deformed screw gear.The back-end wheel was received in the home position.Resistance was felt when advancing the back-end wheel and the tip did not move.Upon removal of the back-end wheel, deformation was evident to the threads and a kink was observed to the hypo tube.No other deformation was evident to the remainder of the device.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II AUI STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key24483564
Report Number9612164-2026-01077
Device Sequence Number16111832
Product Code MIH
UDI-Device Identifier00643169232594
UDI-Public(01)00643169232594(17)260509
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 04/12/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/09/2026
Device Model NumberETUF2814C102E
Device Catalogue NumberETUF2814C102E
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer02/27/2026
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/27/2026
Supplement Date Received by Manufacturer03/02/2026
03/31/2026
04/10/2026
Initial Report FDA Received Date03/02/2026
Supplement Report FDA Received Date03/03/2026
04/10/2026
04/13/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/09/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age73 YR
Patient SexFemale
-
-